Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Paip2 Inhibitors

Paip2 inhibitors represent a distinct class of chemical compounds designed to specifically target and inhibit Poly(A) Binding Protein Interacting Protein 2 (Paip2). Paip2 plays a pivotal role in regulating mRNA translation by interacting with poly(A) binding proteins (PABPs), which are critical for maintaining the stability and efficiency of mRNA translation. Inhibitors targeting Paip2 are characterized by their molecular architecture, which allows them to bind selectively to Paip2, disrupting its interaction with PABPs. This selective binding is achieved through the careful design of these molecules, which often involves the mimicry or antagonism of Paip2's natural binding sites. The chemical structure of Paip2 inhibitors typically includes specific functional groups and moieties tailored to interact with key domains of the Paip2 protein, such as those involved in PABP binding.

The development and exploration of Paip2 inhibitors encompass a range of sophisticated chemical and biological techniques. These include high-throughput screening to identify inhibitory compounds, followed by iterative chemical synthesis and modification to enhance selectivity and binding affinity. Structural biology methods, such as X-ray crystallography or NMR spectroscopy, are employed to elucidate the precise molecular interactions between Paip2 inhibitors and the Paip2 protein. This detailed understanding aids in refining the inhibitors' design, making them more effective in binding to Paip2. Additionally, computational modeling plays a crucial role in predicting how modifications to the chemical structure of these inhibitors will impact their interaction with Paip2, guiding the synthesis of more effective compounds. The physicochemical properties of Paip2 inhibitors, like solubility, stability, and molecular weight, are also critical factors in their development. These properties are optimized to ensure efficient interaction with the Paip2 protein, enhancing the overall efficacy of the inhibitors in a cellular context without affecting their stability and solubility.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin binds to Hsp90, potentially destabilizing its client proteins and affecting the stability of proteins that regulate Paip2 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can alter signaling pathways and may indirectly decrease Paip2 transcription.

SN 38

86639-52-3sc-203697
sc-203697A
sc-203697B
10 mg
50 mg
500 mg
$119.00
$342.00
$883.00
19
(3)

SN 38 is an active metabolite of irinotecan that inhibits Topoisomerase I, potentially leading to reduced transcription of Paip2.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

17-AAG selectively inhibits Hsp90, which might affect protein folding and the stability of factors that regulate Paip2.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide inhibits Topoisomerase II, which can lead to DNA damage and potentially downregulate Paip2 expression.

Kenpaullone

142273-20-9sc-200643
sc-200643A
sc-200643B
sc-200643C
1 mg
5 mg
10 mg
25 mg
$61.00
$153.00
$231.00
$505.00
1
(1)

Kenpaullone is a cyclin-dependent kinase inhibitor that may alter cell cycle progression and Paip2 gene expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin can modulate a variety of signaling pathways and might influence transcription factors related to Paip2 expression.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$166.00
$322.00
436
(1)

Puromycin causes premature chain termination during protein translation, which could lead to cellular stress affecting Paip2 expression.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Roscovitine is a cyclin-dependent kinase inhibitor, which might influence cell cycle-dependent expression of Paip2.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor that may modify signaling pathways relevant to the regulation of Paip2.